TY - JOUR
T1 - Klebsiella pneumoniae induces host metabolic stress that promotes tolerance to pulmonary infection
AU - Wong Fok Lung, Tania
AU - Charytonowicz, Daniel
AU - Beaumont, Kristin G.
AU - Shah, Shivang S.
AU - Sridhar, Shwetha H.
AU - Gorrie, Claire L.
AU - Mu, Andre
AU - Hofstaedter, Casey E.
AU - Varisco, David
AU - McConville, Thomas H.
AU - Drikic, Marija
AU - Fowler, Brandon
AU - Urso, Andreacarola
AU - Shi, Wei
AU - Fucich, Dario
AU - Annavajhala, Medini K.
AU - Khan, Ibrahim N.
AU - Oussenko, Irina
AU - Francoeur, Nancy
AU - Smith, Melissa L.
AU - Stockwell, Brent R.
AU - Lewis, Ian A.
AU - Hachani, Abderrahman
AU - Upadhyay Baskota, Swikrity
AU - Uhlemann, Anne Catrin
AU - Ahn, Danielle
AU - Ernst, Robert K.
AU - Howden, Benjamin P.
AU - Sebra, Robert
AU - Prince, Alice
N1 - Publisher Copyright:
© 2022 The Author(s)
PY - 2022/5/3
Y1 - 2022/5/3
N2 - K. pneumoniae sequence type 258 (Kp ST258) is a major cause of healthcare-associated pneumonia. However, it remains unclear how it causes protracted courses of infection in spite of its expression of immunostimulatory lipopolysaccharide, which should activate a brisk inflammatory response and bacterial clearance. We predicted that the metabolic stress induced by the bacteria in the host cells shapes an immune response that tolerates infection. We combined in situ metabolic imaging and transcriptional analyses to demonstrate that Kp ST258 activates host glutaminolysis and fatty acid oxidation. This response creates an oxidant-rich microenvironment conducive to the accumulation of anti-inflammatory myeloid cells. In this setting, metabolically active Kp ST258 elicits a disease-tolerant immune response. The bacteria, in turn, adapt to airway oxidants by upregulating the type VI secretion system, which is highly conserved across ST258 strains worldwide. Thus, much of the global success of Kp ST258 in hospital settings can be explained by the metabolic activity provoked in the host that promotes disease tolerance.
AB - K. pneumoniae sequence type 258 (Kp ST258) is a major cause of healthcare-associated pneumonia. However, it remains unclear how it causes protracted courses of infection in spite of its expression of immunostimulatory lipopolysaccharide, which should activate a brisk inflammatory response and bacterial clearance. We predicted that the metabolic stress induced by the bacteria in the host cells shapes an immune response that tolerates infection. We combined in situ metabolic imaging and transcriptional analyses to demonstrate that Kp ST258 activates host glutaminolysis and fatty acid oxidation. This response creates an oxidant-rich microenvironment conducive to the accumulation of anti-inflammatory myeloid cells. In this setting, metabolically active Kp ST258 elicits a disease-tolerant immune response. The bacteria, in turn, adapt to airway oxidants by upregulating the type VI secretion system, which is highly conserved across ST258 strains worldwide. Thus, much of the global success of Kp ST258 in hospital settings can be explained by the metabolic activity provoked in the host that promotes disease tolerance.
KW - Klebsiella pneumoniae
KW - M2 macrophages
KW - MDSCs
KW - bacterial adaptation
KW - disease tolerance
KW - immunometabolism
KW - immunosuppression
KW - itaconate
KW - pulmonary infection
KW - type 6 secretion system
UR - http://www.scopus.com/inward/record.url?scp=85129445212&partnerID=8YFLogxK
U2 - 10.1016/j.cmet.2022.03.009
DO - 10.1016/j.cmet.2022.03.009
M3 - Article
C2 - 35413274
AN - SCOPUS:85129445212
SN - 1550-4131
VL - 34
SP - 761-774.e9
JO - Cell Metabolism
JF - Cell Metabolism
IS - 5
ER -